glp-1 drug shortages The boom created one of the strangest health stories of the decade. Drugs built for diabetes and obesity became pop-culture products, then supply opened the door to falsified versions. WHO Drug shortages created opportunities for
Description
Fueled by scientific breakthroughsmost notably the success of glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide and tirzepatidethe obesity therapeutics market is now one of the fastest-growing sectors globally

Hair loss caused by alopecia areata can sometimes be managed

There are also ongoing trials exploring the role of GLP-1 agonists in addiction
Pediatr Drugs 28 , 239248 (2026)
doi: 10.1186/1471-2296-14-195

One such option is Endoscopic Sleeve Gastroplasty, often called ESG
